24 Mar 24 March is World TB Day
Every year, the world commemorates World Tuberculosis (TB) Day on 24 March to raise awareness of the impact of the disease for one’s health as well as social and economic consequences. ...
News & Updates
22 Mar SAHPRA exhibits MedSafety App at 2023 Pharmacy Show
Johannesburg - The South African Health Products Regulatory Authority (SAHPRA) participated in the fourth edition of 2023 The Pharmacy Show (TPS) during 15-16 March 2023, at the Sandton Convention Centre. The Pharmacy Show is the leading networking and business event for everyone involved in supplying, marketing,...
15 Mar SAHPRA participates in 2023 SAAHIP Annual Conference
KwaZulu-Natal - The South African Health Products Regulatory Authority (SAHPRA) has participated in the 36th Annual South African Association of Hospital and Institutional Pharmacists (SAAHIP) Annual Conference during 09 -11 March 2023, in KwaZulu-Natal. SAHPRA also had an opportunity to exhibit where information was shared...
01 Mar Removing Barriers and Promoting Access to Health Products
1 March 2023 The COVID-19 pandemic turned the spotlight on the South African Health Products Regulator (SAHPRA), with many people expecting the regulator to approve medication that would see the end to the virus, but more often with limited understanding of the processes involved in reaching...
23 Feb SAHPRA hosts Regional QMS Technical Working Group Workshop
Pretoria, 23 February 2023 - The South African Health Products Regulatory Authority (SAHPRA) hosted the Regional Quality Management Systems (QMS) Technical Working Group Workshop during 20 - 23 February 2023 at Protea Hotel – OR Tambo Airport. The participating countries included: Angola, Botswana, Eswatini, Lesotho,...
30 Jan SAHPRA registers Paxlovid, an anti-viral medicine for COVID-19
Pretoria, 30 January 2023 – The South African Health Products Regulatory Authority (SAHPRA) has registered Paxlovid, an anti-viral medicine manufactured by Pfizer, to treat COVID-19. Paxlovid, which contains Nirmatrelvir (150mg) and Ritonavir (100mg), is a medicine that is used for the treatment of mild to moderate...
04 Jan Register for an Africa Continental Good Regulatory Practice Workshop
The US Agency for International Development (USAID), the American National Standards Institute (ANSI), and Advanced Medical Technology Association (AdvaMed) is hosting a Workshop on Good Regulatory Practices and its implementation in the Medical Device Sector on 31 January and 01 February 2023. To register, click here. Read...
15 Dec Long Acting Cabotegravir, a preventative ARV for HIV
Many of you have heard about this strange sounding medication, Cabotegravir (Cah-bot-er-grah-ver), floating around news broadcasts and print outlets. Well, this medication is a Human Immunodeficiency Virus (HIV) anti-retroviral (ARV) that has been recently approved by the South African Health Products Regulatory Authority (SAHPRA). What is...
02 Dec SAHPRA registers new long-acting HIV Pre-exposure prophylaxis
Pretoria, 2 December 2022 – The South African Health Products Regulatory Authority (SAHPRA) has registered Cabotegravir (Apretude 600 mg/3ml injection), a long-acting HIV pre-exposure prophylactic. Cabotegravir is an antiretroviral drug (ARV) that people living with HIV may use, together with other ARVs, to keep the virus...
02 Dec SAHPRA celebrates the conclusion of the backlog clearance project
Pretoria, 2 December 2022 – With the establishment of the South African Health Products Regulatory Authority (SAHPRA) in February 2018, the regulatory authority inherited a backlog of approximately 16 000 new product and variation applications from its predecessor, the Medicines Control Council (MCC). As is generally...